Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake

Cristiane Metran-Nascente, Ivan Yeung, Douglass C. Vines, Ur Metser, Neesha C. Dhani, David Green, Michael Milosevic, David Jaffray and David W. Hedley
Journal of Nuclear Medicine March 2016, 57 (3) 361-366; DOI: https://doi.org/10.2967/jnumed.115.167650
Cristiane Metran-Nascente
1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Yeung
2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglass C. Vines
2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ur Metser
3Department of Medical Imaging, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neesha C. Dhani
1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Green
2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Milosevic
2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Jaffray
2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Hedley
1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    (A) 18F-FAZA PET images with intensity bars for SUV (left) and fused images (right) obtained from primary pancreatic cancers (dashed yellow lines) showing high (top) and low (bottom) tracer uptake. Biliary stents can be seen in each patient. (B) Histograms of SUV to mean muscle SUV ratios for individual voxels from primary tumor (solid line) and from skeletal muscle (dotted line). HF is derived as percentage of tumor voxels exceeding 3 SDs of the mean value for skeletal muscle, indicated by cursor. (C) Results for tumor SUVmax and HF obtained from 20 patients with static scans, arranged in rank order of HF.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    (A) HF of primary tumor plotted against HF obtained for corresponding normal pancreas. (B) HF plotted against tumor volume assessed by CT.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    (A) HFs in rank order, showing tumors that showed no radiologic evidence of metastases and those with overt metastatic disease. (B) Group means of HF for tumors with and without evident metastases. Error bars are SEM; difference is nonsignificant.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    18F-FAZA uptake at metastatic sites. Upper 4 panels are representative sections showing liver metastases (arrows). High background uptake in normal liver obscures uptake by metastases in PET images, but these could be contoured using CT image, allowing measurement of 18F-FAZA uptake. Lower 4 panels are axial and coronal sections from patient with advanced peritoneal metastases, for which increased 18F-FAZA uptake is easily seen in PET images. SUVs represented in intensity bars.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    (A and B) Tumor perfusion, derived from dynamic PET scans, plotted against 18F-FAZA uptake in corresponding static scan, expressed as SUVmax and HF. (C) Correlation between HF values calculated using individual muscle distribution for defining threshold vs. those using pooled muscle distribution. There is strong correlation between the 2 methods (R2 = 0.95). (D) Pooled normalized SUV distribution over 20 patients consisting of 5,705 voxels in total. Data fit normal distribution function.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 57 (3)
Journal of Nuclear Medicine
Vol. 57, Issue 3
March 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake
Cristiane Metran-Nascente, Ivan Yeung, Douglass C. Vines, Ur Metser, Neesha C. Dhani, David Green, Michael Milosevic, David Jaffray, David W. Hedley
Journal of Nuclear Medicine Mar 2016, 57 (3) 361-366; DOI: 10.2967/jnumed.115.167650

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake
Cristiane Metran-Nascente, Ivan Yeung, Douglass C. Vines, Ur Metser, Neesha C. Dhani, David Green, Michael Milosevic, David Jaffray, David W. Hedley
Journal of Nuclear Medicine Mar 2016, 57 (3) 361-366; DOI: 10.2967/jnumed.115.167650
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

Keywords

  • hypoxia
  • pancreatic cancer
  • FAZA
  • perfusion
SNMMI

© 2025 SNMMI

Powered by HighWire